Researchers have significantly improved its development of a new therapy for ATTR-CM, leveraging the investigational drug. Preliminary patient data reveals promising outcomes for patients affected from a debilitating https://bridgebio717448.activosblog.com/40646127/company-advances-amyloidosis-management-using-the-therapy